Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

UUroGen Pharma Ltd.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
U

UroGen Pharma Ltd.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $72.46M. Net result −$14.35M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $72.46M. Running result $72.46M. Jelmyto: $22.03M. Zusduri: $50.43M.
  • Cost of revenue: −$6.57M. Running result $65.88M.
  • Gross profit: $65.88M. Running result $65.88M.
  • Research and development expenses: −$17.34M. Running result $48.55M.
  • Selling, general and administrative expenses: −$48.44M. Running result $111K.
  • Operating income: $111K. Running result $111K.
  • Other expense: −$8.83M. Running result −$8.72M.
  • Pre-tax loss: −$8.72M. Running result −$8.72M.
  • Income tax expense: −$5.63M. Running result −$14.35M.
  • Net loss: −$14.35M. Running result −$14.35M.